GILEAD SCIENCES, INC. - Common Stock (GILD)

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / Common Stock
Shares outstanding
1,240,722,841
Total 13F shares
1,003,983,340
Share change
+11,093,574
Total reported value
$61,982,373,182
Put/Call ratio
76%
Price per share
$61.69
Number of holders
1,570
Value change
+$689,958,176
Number of buys
822
Number of sells
621

Institutional Holders of GILEAD SCIENCES, INC. - Common Stock (GILD) as of Q3 2022

As of 30 Sep 2022, GILEAD SCIENCES, INC. - Common Stock (GILD) was held by 1,570 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,003,983,340 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, Capital World Investors, Capital Research Global Investors, Dodge & Cox, GEODE CAPITAL MANAGEMENT, LLC, Bank of New York Mellon Corp, MORGAN STANLEY, and NORTHERN TRUST CORP. This page lists 1,572 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.